BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Alex Kelly Joins Bausch & Lomb as Vice President Investor Relations


5/9/2013 7:01:24 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCHESTER, N.Y., May 9, 2013 /PRNewswire/ -- Bausch + Lomb, the global eye health company, today announced that Alex Kelly has joined the company as vice president, Investor Relations, reporting to the company's president and chief financial officer, Bob Bertolini. In this capacity, Kelly will serve as the primary point of contact for the investment community.

(Logo: http://photos.prnewswire.com/prnh/20121221/MM34011LOGO )

"I have had the pleasure of working closely with Alex over many years," said Bertolini. "He's a world-class executive and we are very fortunate to have him join the Bausch + Lomb team."

Kelly joins us from Merck & Co., where he served most recently as vice president, Investor Relations. Prior to Merck, he was group vice president of Global Communications and Investor Relations at Schering-Plough. Earlier in his career, Kelly held senior Investor Relations roles with Novartis and Pharmacia & Upjohn. A pharmacist by training, he started his career in Pharmaceutical sales at the Upjohn Company where he was later a district sales manager.

"Having seen the progress Bausch + Lomb has made in transforming itself over the last three years, this is an exciting time to join the company," said Kelly. "I look forward to working with the management team to help Bausch + Lomb realize its vision of becoming the best global eye health company."

Adam Grossberg, vice president of Global Communications will transition his Investor Relations responsibilities to Kelly, and take on added responsibility for the company's Global Branding, Advertising & Digital Initiatives.

About Bausch + Lomb
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries. Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.

SOURCE Bausch + Lomb

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES